Diagnosis and treatment of depression in late life

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL.4, 1998, Pages 80-91

  Zisook, Sidney ^a   Downs, Nancy S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMPHETAMINE DERIVATIVE; ASTEMIZOLE; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CISAPRIDE; CYTOCHROME P450; DESIPRAMINE; DOPAMINE; FLUOXETINE; HISTAMINE H1 RECEPTOR; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PETHIDINE; SELEGILINE; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TERFENADINE; THYROID HORMONE; TRAZODONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; TYRAMINE; VALPROIC ACID; VENLAFAXINE;

AGED; ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; COUNSELING; DEPRESSION; DYSTHYMIA; ELECTROCONVULSIVE THERAPY; FAMILY; HUMAN; INSOMNIA; LIFE EVENT; MORTALITY; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; RISK FACTOR; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION;

ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; BUPROPION; COGNITION DISORDERS; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; DYSTHYMIC DISORDER; ELECTROCONVULSIVE THERAPY; FAMILY; HEALTH EDUCATION; HUMANS; LIFE CHANGE EVENTS; MIDDLE AGED; PATIENT EDUCATION; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTHERAPY; SEVERITY OF ILLNESS INDEX;

EID: 0031892570     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (98)

1. Aging America, Trends and Projections. Washington, DC: U.S. Senate Special Committee on Aging, the American Association of Retired Persons, the Federal Council on the Aging, and the U.S. Administration on Aging; 1991:7
2. Diagnosis and treatment of depression in late life: NIH Consensus Development Panel on Depression in Late Life. JAMA 1992;268(8):1018-1024
3. Robins LN, Regier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: The Free Press, 1991
4. Blazer DG. Depression in Late Life, 2nd ed. St. Louis, Mo: Mosby; 1993
5. Murrell SA, Himmelfarb S, Wright K. Prevalence of depression and its correlates in older adults. Journal of Epidemiology 1983;117:173-185
6. Berkman LF, Berkman CS, Kasl S, et al. Depressive symptoms in relation to physical health and functioning in the elderly. Journal of Epidemiology 1986;124:372-388
7. Kennedy GJ, Kelman HR, Thomas C, et al. Hierarchy of characteristics associated with depressive symptoms in an urban elderly sample. Am J Psychiatry 1989;146:220-225
8. Boorson S, Barnes RA, Kukull WA, et al. Symptomatic depression in elderly medical outpatients. I: prevalence, demography, and health services utilization. J Am Geriatr Soc 1986;34:341-347
9. Barrett JE, Barrett JA, Oxman TE, et al. The prevalence of psychiatric disorders in a primary care practice. Arch Gen Psychiatry 1988;45:1100-1106
10. Koenig HG, Meador KG, Cohen HG, et al. Depression in elderly hospitalized patients with medical illness. Arch Intern Med 1988;148:1929-1936
11. O'Riordan TGB, Hayes JP, Shelley R, et al. The prevalence of depression in an acute geriatric medical assessment unit. Int J Geriatr Psychiatry 1989; 4:17-21
12. Rapp SR, Walsh DA, Parisi SA, et al. Detecting depression in elderly medical inpatients. Journal of Counselling in Clinical Psychology 1988;36: 509-513
13. Parmelee PA, Katz IR, Lawton MP. Depression among institutionalized aging: assessment in prevalence estimation. J Gerontol A Biol Sci Med Sci 1989;44:M22-M29
14. Ames D. Depression among elderly residents of local-authority residential homes: its nature and efficacy of intervention. Br J Psychiatry 1990; 156:667-675
15. Katz IR, Parmelee PA. Depression in elderly patients in residential care settings. In: Schneider LS, Reynolds CF, Lebowitz BD, et al, eds. Diagnosis and Treatment of Depression in the Elderly: Results of the NIH Consensus Development Conference. Washington, DC: American Psychiatric Press; 1994:437-468
16. Lebowitz BD. Diagnosis and treatment of depression in late life: an overview of the NIH consensus statement. Am J Geriatr Psychiatr 1996;4(1, suppl):S3-S6
17. Cole MG, Bellavance F. The prognosis of depression in old age. Am J Geriatr Psychiatry 1997;5:4-14
18. Murphy E. The course and outcome of depression in late life. In: Schneider LS, Reynolds CF, Lebowitz BD, et al, eds. Diagnosis and Treatment of Depression in the Elderly: Results of the NIH Consensus Development Conference. Washington, DC: American Psychiatric Association; 1994:81-98
19. Dorgan CA, ed. Statistical Record of Health & Medicine. New York, NY: International Thomson Publishing Company; 1995
20. Cohen-Cole SA, Stoudemire A. Major depression and physical illness. Psychiatr Clin North Am 1987;10:1-17
21. Zubenko GS, Mulsant BH, Rifai AH, et al. Impact of acute psychiatric inpatient treatment on major depression in late life and prediction of response. Am J Psychiatry 1994;151:987-994
22. Brown RP, Sweeny J. Loutsch E, et al. Involutional melancholia revisited. Am J Psychiatry 1984;141:24-28
23. Ruegg RG, Zisook S, Swerdlow NR. Depression in the aged. Psychiatr Clin North Am 1988:11(1):83-99
24. Blazer DG. Depression in elderly: myths and misconceptions. Psychiatr Clin North Am 1997;21(1):111-119
25. Massie MJ, Holland JC. Depression and the cancer patient. J Clin Psychiatry 1990;51(7, suppl):12-17
26. Cavanaugh SV. Diagnosing depression in the hospitalized patient with chronic medical illness. J Clin Psychiatry 1984;45(3, sec 2):13-17
27. Kathol RG, Mutgi A, Williams J, et al. Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry 1990; 147:1021-1024
28. Salzman C. Antidepressant treatment in the elderly. Presented at the West Coast Geriatric Psychiatry Conference; September 28-October 1, 1995; San Diego, Calif
29. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive status of patients for the clinician. J Psychiatr Res 1975;12:189-198
30. Reifler BV, Larson E, Hanley R. Coexistence of cognitive impairment and depression in psychiatric outpatients. Am J Psychiatry 1982;139:623-626
31. Himmelhoch JM, Auchenbach R, Fuchs CZ. The dilemma of depression in the elderly. J Clin Psychiatry 1982;43(9, sec 2):26-32
32. Riefler BV, Teri L, Raskind M, et al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry 1989;146:45-49
33. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149:443-454
34. Alexopoulos GS, Meyers BS, Young RC, et al. The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry 1993;150:1693-1699
35. Kramer SI, Riefler BV. Depression, dementia and reversible dementia. Clin Geriatr Med 1992;8:289-297
36. Stroebe W, Stroebe M. Bereavement and Health. New York, NY: Cambridge University Press; 1987
37. Kaprio J, Koskenvuo M, Rita H. Mortality after bereavement: a prospective study of 95,647 widowed persons. Am J Public Health 1987;77: 283-287
38. Zisook S, Shuchter SR. Bereavement. In: Current Psychiatric Therapy, II. Philadelphia, Pa: Saunders; 1997:248-252
39. Zisook S, Shuchter SR. Uncomplicated bereavement. J Clin Psychiatry 1993;54:365-372
40. Zisook S, Shuchter SR. Major depression associated with widowhood. Am J Geriatr Psychiatry 1993;147:316-326
41. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989; 262:914-919
42. Kennedy GJ, Kelman HR, Thomas C. Persistence and remission of depressive symptoms in late life. Am J Psychiatry 1991;148:174-178
43. Dalack GW, Roose SP. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 1990;51(7, suppl): 4-9
44. Morris PL, Robinson RG, Andrzejewski P, et al. Association of depression with 10 year poststroke mortality. Am J Psychiatry 1993;150(1):124-129
45. Mossey JM, Knott K, Craik R. The effects of persistent depressive symptoms on hip fracture recovery. J Gerontol A Biol Sci Med Sci 1990;45(5):M163-M168
46. Pearson JL, Teri L, Riefler BV, et al. Functional status and cognitive impairment in Alzheimer's patients with and without depression. J Am Geriatr Soc 1989;37:1117-1121
47. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. JAMA 1993;270:1819-1825
48. Frank E, Karp JF, Rush AJ. Efficacy of treatments for major depression. Psychopharmacol Bull 1993;29:457-475
49. Niederehe G. Psychosocial treatments with depressed older adults: a research update. Am J Geriatr Psychiatry 1996;4(suppl 1):S66-S78
50. Reynolds CF, Frank E, Perel JM, et al. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report. Am J Psychiatry 1992;149:1687-1692
51. Thompson LW, Gallagher D, Breckenridge JS. Comparative effectiveness of psychotherapies for depressed elders. J Consult Clin Psychol 1987;55: 385-390
52. Shuchter SR, Downs N, Zisook S. Biologically Informed Treatment for Depression. New York, NY: Guilford Press; 1996
53. Robinson RG, Morris PLP, Fedoroff JP. Depression and cerebrovascular disease. J Clin Psychiatry 1990;51(7, suppl):26-31
54. Salzman C. Clinical Geriatric Psychopharmacology. Baltimore, Md: Williams & Wilkins; 1992
55. Finch CE. Neuroendocrine and autonomic aspects of aging. In: Finch CE, Hayflick L, eds. Handbook of the Biology of Aging. New York. NY: Van Nostrand Reinhold; 1977:262-280
56. Salzman C. Medication compliance in the elderly. J Clin Psychiatry 1995;56(1, suppl):18-22
57. Lamy PP, Salzman C, Nevis-Oelsen J. Drug prescribing patterns, risks, and compliance guidelines. In: Salzman C, ed. Clinical Geriatric Psychopharmacology, 2nd ed. Baltimore, Md: Williams & Wilkins; 1992:15-37
58. Ostrum RE, Hammarlund ER, Christensen DB, et al. Medication usage in an elderly population. Med Care 1988;23:157-170
59. Jackson JE, Ramsdell JW, Renvall M, et al. Reliability of drug histories in a specialized geriatric outpatient clinic. J Gen Intern Med 1984;4:39-43
60. Richelson E. Synaptic effects of antidepressants. J Clin Psychopharmacol 1996;16(suppl 2):1S-9S
61. Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol 1997; 17(suppl 1):2S-18S
62. Zisook S. A clinical overview of monoamine oxidase inhibitors. Psychosomatics 1985;26:240-251
63. Georgotas A, McCue RE, Friedman E, et al. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 1989;46:783-786
64. Sunderland T, Cohen RM, Molchan S. High-dose selegiline in treatment-resistant older depressive patients. Arch Gen Psychiatry 1994;51:607-615
65. Tune L, Carr S, Hoag E, et al. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 1992;149:1393-1394
66. Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs. tricyclic antidepressants. JAMA 1996;275:1897-1902
67. Schneider LS. Pharmacologic considerations in the treatment of late-life depression. Am J Geriatr Psychiatr 1996;4(suppl 1):S51-S65
68. Roose SP, Glassman AH, Attia E, et al. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994;151:1735-1739
69. Newhouse PA. Use of serotonin selective reuptake inhibitors in geriatric depression. J Clin Psychiatry 1996;57(suppl 5):12-22
70. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311-320
71. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16:356-362
72. Sporer KA. The serotonin syndrome: implicated drugs, pathophysiology and management. Drug Saf 1995;13:94-104
73. Preskorn SH. Recent pharmacologic advances in antidepressant therapy for the elderly. Am J Med 1993;94(suppl 5A):2S-12S
74. Sprouse J, Clarke T, Reynolds L, et al. Comparison of the effects of sertraline and its metabolite methylsertraline on blockade of central 5-HT reuptake in vivo. Neuropsychopharmacology 1996;14:225-231
75. Sachs GS, Lafer B, Stoll AL, et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994;55:391-393
76. Haykal RF, Akiskal HS. Bupropion as a promising approach to rapid cycling bipolar II patients. J Clin Psychiatry 1990;51:450-455
77. Walker PW, Cole JO, Gardner EA, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 1993;54:459-465
78. Mildener B, Kramer-Ginsberg E, Greenwald B, et al. Ruoxetine and bupropion in old-old depressives. In: New Research Program and Abstracts of the 145th Annual Meeting of the American Psychiatric Association; May 4, 1992; New York, NY. Abstract NR103:72
79. Giakas WJ, Miller HL, Hensala JD, et al. Fluoxetine versus bupropion in geriatric depression. In: New Research Program and Abstracts of the 146th Annual Meeting of the American Psychiatric Association; May 26, 1993; San Francisco, Calif. Abstract NR479:180
80. Kane JM, Cole K, Sarantakos S, et al. Safety and efficacy of bupropion in elderly patients: preliminary observations. J Clin Psychiatry 1983;44(5, sec 2):134-136
81. Branconnier RJ, Cole JO, Ghazvinian S, et al. Clinical pharmacology of bupropion and imipramine in elderly depressives. J Clin Psychiatry 1983;44(5, sec 2):130-133
82. Farid FF, Wenger TL, Tsai SY, et al. Use of bupropion in patients who exhibit orthostatic hypotension on tricyclic antidepressants. J Clin Psychiatry 1983:44(5, sec 2):170-173
83. Roose SP, Glassman AH, Giardina EGV, et al. Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychopharmacol 1987;7:247-251
84. Roose SP, Dalack GW, Glassman AH, et al. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 1991; 148:512-516
85. Schweizer E, Weise C, Clary C, et al. Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol 1991; 11:233-236
86. Gerner R, Estabrook W, Steuer J, et al. Treatment of geriatric depression with trazodone, imipramine, and placebo: a double-blind study. J Clin Psychiatry 1980;41:216-220
87. Feiger A, Kiev A, Shrivastava RK, et al. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996;57(suppl 2):53-62
88. Bremner JD. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression. J Clin Psychiatry 1995;56:519-525
89. Satel SL, Nelson JC. Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry 1989;50:241-249
90. Mulsant BH, Rosen J, Thornton JE, et al. A prospective naturalistic study of electroconvulsive therapy in late-life depression. J Geriatr Psychiatry Neurol 1991;4:3-13
91. Philibert RA, Richards L, Lynch CF, et al. Effect of ECT on mortality and clinical outcome in geriatric unipolar depression. J Clin Psychiatry 1995; 56:390-394
92. Zielinski RJ, Roose SP, Devanand DP, et al. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993; 150:904-909
93. Sackheim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990;10:96-104
94. Oppenheim G, Zohar J, Sharpiro B, et al. The role of estrogen in treating resistant depression. In: Zohar J, Belmaker RH, eds. Treating Resistant Depression. New York, NY: PMA Publishing; 1987:357-366
95. Georgotas A, McCue RE. The additional benefit of extending an antidepressant trial past seven weeks in the depressed elderly. Int J Geriatr Psychiatry 1989;4:191-195
96. Reynolds CF III. Treatment of depression in special populations. J Clin Psychiatry 1992;53(9, suppl):45-53
97. Dunner DL, Zisook S, Billow AA, et al. A prospective safety surveillance study for bupropion sustained release in the treatment of depression. J Clin Psychiatry. In press
98. Physicians' Desk Reference. Montvale, NJ: Medical Economics; 1997